Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000640475 | SCV000762067 | likely pathogenic | Androgen resistance syndrome; Kennedy disease | 2017-11-10 | criteria provided, single submitter | clinical testing | This sequence change replaces valine with isoleucine at codon 685 of the AR protein (p.Val685Ile). The valine residue is highly conserved and there is a small physicochemical difference between valine and isoleucine. This variant is not present in population databases (ExAC no frequency). This variant has been reported in an individual affected with complete androgen insensitivity syndrome (PMID: 10425033). Experimental studies have shown that this missense change inhibits the androgen binding activity of the androgen receptor protein (PMID: 10425033). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. |